
GL Stock Forecast & Price Target
GL Analyst Ratings
Bulls say
Globe Life Inc. demonstrates a robust growth trajectory, with expected life premium growth targeted at 4.0%-4.5% and health premium projected to rise by 14%-16% in the upcoming year, indicating strong demand for their products. The company's strategic marketing efforts are anticipated to yield a 10% increase in leads generated for exclusive agencies, supporting sustained sales momentum across its operational segments. Additionally, favorable mortality experience and adjustments yielded a total remeasurement gain of $150 million in Q3, reflecting the strength of Globe Life's underwriting and financial health, which underpins its long-term growth outlook.
Bears say
Globe Life Inc. has projected minimal growth in operating earnings per share for 2026, with a midpoint estimate of $14.60-$15.30 reflecting only 3% growth, primarily due to significant assumption updates impacting profitability. Additionally, the anticipated decline in Life remeasurement gains, forecasted at $50-$100 million compared to $192 million from the previous year, raises concerns about the sustainability of the company's earnings. Compounding this negative outlook are operational risks, including potential fines from an EEOC review, increased health utilization leading to margin pressure, and challenges in salesforce recruiting that could adversely affect revenue growth.
This aggregate rating is based on analysts' research of Globe Life Inc and is not a guaranteed prediction by Public.com or investment advice.
GL Analyst Forecast & Price Prediction
Start investing in GL
Order type
Buy in
Order amount
Est. shares
0 shares